病变特异性冠状动脉周围脂肪组织CT衰减值改善冠心病主要不良心血管事件风险预测
该回顾性研究纳入608例2014年1月至2018年12月接受冠状动脉CTA的冠心病患者,比较病变特异性PCATa与PCATa-RCA、PCATa-LAD对MACE的预测价值。病变特异性PCATa是MACE的独立预测因子(校正HR=1.108,P<.001),将其加入传统因素模型后C-statistic由0.750升至0.791(P=.005),AUC由0.770升至0.820(P=.019),预测效能优于PCATa-RCA和PCATa-LAD。
要点
- 病变特异性PCATa是MACE的独立预测因子(校正HR=1.108,P<.001)。
- 加入病变特异性PCATa后模型C-statistic由0.750升至0.791(P=.005)。
- 病变特异性PCATa预测效能优于PCATa-RCA和PCATa-LAD。
核心结论
- 病变特异性PCATa可改善冠心病患者MACE风险预测,且优于PCATa-RCA和PCATa-LAD。
研究设计与样本
- 回顾性纳入608例2014年1月至2018年12月接受冠状动脉CTA的冠心病患者,收集临床危险因素、斑块特征、病变特异性PCATa、PCATa-RCA和PCATa-LAD,建立四个模型(模型A为传统因素,模型B为传统因素+PCATa-RCA,模型C为传统因素+PCATa-LAD,模型D为传统因素+病变特异性PCATa),以C-statistic、AUC和NRI评估预后效能。
诊断标准与关键数值
- MACE定义为心血管死亡、非致死性心肌梗死、非计划血运重建和不稳定型心绞痛住院。
- 病变特异性PCATa为MACE独立预测因子,校正HR=1.108(P<.001)。
- C-statistic由模型A的0.750升至模型B的0.762(P=.078)、模型C的0.773(P=.046)、模型D的0.791(P=.005)。
- AUC由模型A的0.770升至模型B的0.793(P=.027)、模型C的0.793(P=.387)、模型D的0.820(P=.019)。
- 与模型A相比,模型B、C、D的NRI分别为0.243(-0.323至0.792,P=.392)、0.428(-0.012至0.835,P=.048)、0.708(0.152-1.016,P=.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether lesion-specific pericoronary adipose tissue CT attenuation (PCATa) is superior to PCATa around the proximal right coronary artery (PCATa-RCA) and left anterior descending artery (PCATa-LAD) for major adverse cardiovascular events (MACE) prediction in coronary artery disease (CAD).
METHODS: Six hundred and eight CAD patients who underwent coronary CTA from January 2014 to December 2018 were retrospectively included, with clinical risk factors, plaque features, lesion-specific PCATa, PCATa-RCA, and PCATa-LAD collected. MACE was defined as cardiovascular death, non-fatal myocardial infarction, unplanned revascularization, and hospitalization for unstable angina. Four models were established, encapsulating traditional factors (Model A), traditional factors and PCATa-RCA (Model B), traditional factors and PCATa-LAD (Model C), and traditional factors and lesion-specific PCATa (Model D). Prognostic performance was evaluated with C-statistic, area under receiver operator characteristic curve (AUC), and net reclassification index (NRI).
RESULTS: Lesion-specific PCATa was an independent predictor for MACE (adjusted hazard ratio = 1.108, P < .001). The C-statistic increased from 0.750 for model A to 0.762 for model B (P = .078), 0.773 for model C (P = .046), and 0.791 for model D (P = .005). The AUC increased from 0.770 for model A to 0.793 for model B (P = .027), 0.793 for model C (P = .387), and 0.820 for model D (P = .019). Compared with model A, the NRIs for models B, C, and D were 0.243 (-0.323 to 0.792, P = .392), 0.428 (-0.012 to 0.835, P = .048), and 0.708 (0.152-1.016, P = .001), respectively.
CONCLUSIONS: Lesion-specific PCATa improves risk prediction of MACE in CAD, which is better than PCATa-RCA and PCATa-LAD.
ADVANCES IN KNOWLEDGE: Lesion-specific PCATa was superior to PCATa-RCA and PCATa-LAD for MACE prediction.
引用
- Chen M, Hao G, Hu S, et al. Lesion-specific pericoronary adipose tissue CT attenuation improves risk prediction of major adverse cardiovascular events in coronary artery disease. Br J Radiol. 2024. PMID: 38263819. doi:10.1093/bjr/tqad017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。